Speaker illustration

Mr Tim Koldenhof

Martini Hospital, Groningen (Netherlands (The))

Rate control with calcium channel blockers versus betablockers in patients with paroxysmal and persistent atrial fibrillation - data from the AFFIRM trial

Event: EHRA 2023

Topic: Rate Control

Session: Atrial Fibrillation - Round 8 - Detection - Treatment

Thumbnail

Rate control drugs differ in the prevention of progression of atrial fibrillation

Event: ESC Congress 2020

Topic: Antiarrhythmic Drug Treatment

Session: Arrhythmias, General ePosters

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb